Drug
Ima970a Plus Cv8102 And Cyclophosphamide
Ima970a Plus Cv8102 And Cyclophosphamide: highest development phase Phase 1/2, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| IMA970A plus CV8102 and Cyclophosphamide NCT03203005 | Phase 1/2 | Hepatocellular Carcinoma |
Latest
No recent events.
Follow Ima970a Plus Cv8102 And Cyclophosphamide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.